Article Text

PDF
Two more benzodiazepines: clorazepate and flurazepam

Abstract

Clorazepate (Tranxene - Boehringer Ingelheim) has recently been introduced with claims by the manufacturer that it is ‘a new but distinctive benzodiazepine’ with a ‘specific anxiolytic action’ in ‘convenient once daily dosage’ and with ‘fewer side-effect problems’. Flurazepam (Dalmane - Roche) has been marketed even more recently as ‘a new and powerful treatment for insomnia’.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.